Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

N/ANot Yet RecruitingNCT07413263

Assiut University75 enrolled

Overview

to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism

to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism and how danger they drugs be

Study Type

OBSERVATIONAL

Enrollment

these drugs used in CML only

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * CML patients free medical history Exclusion Criteria: * diabetic

Change in HbA1c levels in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors

Assessment of change in HbA1c levels in CML patients treated with TKIs.

Time frame: Baseline and 3, 6, 9, and 12 months

Change in lipid profile in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors

Assessment of changes in lipid profile including total cholesterol, triglycerides, LDL, and HDL in CML patients treated with TKIs.

Time frame: Baseline and 3, 6, 9, and 12 months

Nancy Atef Abdou, doctor

CONTACT

mai mostafa kamal, prof

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.